EE10 Cost-Effectiveness of Tenofovir/Lamivudine/Efavirenz Versus Tenofovir/Lamivudine/Dolutegravir for Preventing Mother-to-Child Transmission of HIV in Nigeria

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.262
https://www.valueinhealthjournal.com/article/S1098-3015(22)00463-6/fulltext
Title : EE10 Cost-Effectiveness of Tenofovir/Lamivudine/Efavirenz Versus Tenofovir/Lamivudine/Dolutegravir for Preventing Mother-to-Child Transmission of HIV in Nigeria
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00463-6&doi=10.1016/j.jval.2022.04.262
First page :
Section Title :
Open access? : No
Section Order : 10226
Categories :
Tags :
Regions :
ViH Article Tags :